埃秀马生物科技有限公司于2016年4月在开曼经济特区注册成立,获得了F1 Oncology, Inc.的注资和独家技术授权,是一家处于临床研究阶段、面向亚洲实体瘤市场,开发CAR-T解决方案的生物技术公司,其全资子公司——香港埃秀马和上海埃秀马生物科技有限公司,负责监督位于中国上海和深圳的研发、生产、质量、临床、注册和商业运营部门。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows